SNP recommendation guidelines: Difference between revisions
add TGA summary
m (NZ summary (also limited counter indicators)) |
(add TGA summary) |
||
Line 41: | Line 41: | ||
* Devices regulated according to EU TDP, notified to MHRA, covered under GPSR. | * Devices regulated according to EU TDP, notified to MHRA, covered under GPSR. | ||
* Not currently licensed as medicines. | * Not currently licensed as medicines. | ||
* People who smoke but can't/won't quit. can reduce harm by smoking less or substituting temporarily. Harm reduction benefits are uncertain, but may inspire full quitting. | * People who smoke but can't/won't quit. can reduce harm by smoking less or substituting temporarily. | ||
* Harm reduction benefits are uncertain, but may inspire full quitting. | |||
|- | |||
|See also | |||
|[https://www.gov.uk/government/publications/nicotine-vaping-in-england-2022-evidence-update Nicotine vaping in England: 2022 evidence update] | |||
|} | |} | ||
Line 114: | Line 118: | ||
* Vaping is almost twice as effective as NRTs. | * Vaping is almost twice as effective as NRTs. | ||
* Goal: reducing the strength of your nicotine. | * Goal: reducing the strength of your nicotine. | ||
|} | |||
== Australia == | |||
=== Nicotine vaping products: Information for prescribers === | |||
{| class="wikitable" | |||
|+ | |||
! | |||
! | |||
|- | |||
|Link | |||
|https://www.tga.gov.au/resources/resource/guidance/nicotine-vaping-products-information-prescribers | |||
|- | |||
|Audience | |||
|GPs / PWS | |||
|- | |||
|By | |||
|Therapeutic Goods Administration | |||
|- | |||
|Considerations | |||
| | |||
* NVPs are Schedule 4 (prescription only) medicines, but remain 'unapproved'. | |||
* Their potential efficacy for smoking cessation is currently mixed. | |||
* [https://www.racgp.org.au/clinical-resources/clinical-guidelines/key-racgp-guidelines/view-all-racgp-guidelines/supporting-smoking-cessation/tobacco-harm-reduction RACGP guideliness] apply, and NVPs are '''not first line treatment''' for smoking cessation. | |||
* Availability hinges on authorised prescriber, special access, or personal importation scheme. | |||
* TGA has a [https://www.tga.gov.au/resources/resource/guidance/authorised-prescribers-unapproved-nicotine-vaping-products list of authorised prescribers] (GPs). | |||
|} | |} |